These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31102655)

  • 61. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.
    Zetsche B; Heidenreich M; Mohanraju P; Fedorova I; Kneppers J; DeGennaro EM; Winblad N; Choudhury SR; Abudayyeh OO; Gootenberg JS; Wu WY; Scott DA; Severinov K; van der Oost J; Zhang F
    Nat Biotechnol; 2017 Jan; 35(1):31-34. PubMed ID: 27918548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiplex CRISPR/Cas9-based genome engineering enhanced by Drosha-mediated sgRNA-shRNA structure.
    Yan Q; Xu K; Xing J; Zhang T; Wang X; Wei Z; Ren C; Liu Z; Shao S; Zhang Z
    Sci Rep; 2016 Dec; 6():38970. PubMed ID: 27941919
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
    Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
    BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Recent advances in CRISPR-related transposable elements].
    Ning S; Wu X; Luo Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Dec; 38(12):4371-4384. PubMed ID: 36593183
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transposon-Associated CRISPR-Cas System: A Powerful DNA Insertion Tool.
    Ma W; Xu YS; Sun XM; Huang H
    Trends Microbiol; 2021 Jul; 29(7):565-568. PubMed ID: 33612399
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Applications of CRISPR as a potential therapeutic.
    Luthra R; Kaur S; Bhandari K
    Life Sci; 2021 Nov; 284():119908. PubMed ID: 34453943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System.
    Saw PE; Cui GH; Xu X
    ChemMedChem; 2022 May; 17(9):e202100777. PubMed ID: 35261159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Retron Library Recombineering: Next Powerful Tool for Genome Editing after CRISPR/Cas.
    Kaur N; Pati PK
    ACS Synth Biol; 2024 Apr; 13(4):1019-1025. PubMed ID: 38480006
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CRISPR/Cas gene editing in the human germline.
    Bekaert B; Boel A; Cosemans G; De Witte L; Menten B; Heindryckx B
    Semin Cell Dev Biol; 2022 Nov; 131():93-107. PubMed ID: 35305903
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The CRISPR Revolution: Unraveling the mysteries of Life's genetic code.
    Harsij Z; Ghafoorzadeh Z; Goharian E
    Gene; 2024 Jan; 892():147870. PubMed ID: 37797781
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CRISPR-Cas systems ushered in an era of facile DNA-free genome editing.
    Ajay J; Vandna R
    Semin Cell Dev Biol; 2019 Dec; 96():1-3. PubMed ID: 31551131
    [No Abstract]   [Full Text] [Related]  

  • 74. CRISPR/Cas9-Based Functional Genomics in Human Induced Pluripotent Stem Cell-Derived Models: Can "the Stars Align" for Neurodegenerative Diseases?
    Chen Y; Jong TT; Chen C; Sidransky E
    Mov Disord; 2022 May; 37(5):886-890. PubMed ID: 35338523
    [No Abstract]   [Full Text] [Related]  

  • 75. CRISPRi: a way to integrate iPSC-derived neuronal models.
    Franks SNJ; Heon-Roberts R; Ryan BJ
    Biochem Soc Trans; 2024 Apr; 52(2):539-551. PubMed ID: 38526223
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The CRISPR/Cas System in Human Cancer.
    Bonamino MH; Correia EM
    Adv Exp Med Biol; 2023; 1429():59-71. PubMed ID: 37486516
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Making the cut with PAMless CRISPR-Cas enzymes.
    Christie KA; Kleinstiver BP
    Trends Genet; 2021 Dec; 37(12):1053-1055. PubMed ID: 34563399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System.
    Filho DM; de Carvalho Ribeiro P; Oliveira LF; Dos Santos ALRT; Parreira RC; Pinto MCX; Resende RR
    Stem Cell Rev Rep; 2019 Aug; 15(4):463-473. PubMed ID: 31147819
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The expanding CRISPR toolbox for natural product discovery and engineering in filamentous fungi.
    Woodcraft C; Chooi YH; Roux I
    Nat Prod Rep; 2023 Jan; 40(1):158-173. PubMed ID: 36205232
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CRISPR: a tool with potential for genomic reprogramming in neurological disorders.
    Dhuriya YK; Naik AA
    Mol Biol Rep; 2023 Feb; 50(2):1845-1856. PubMed ID: 36507966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.